NVDA
NVIDIA
-- 138.850 TSLA
Tesla
-- 355.840 INTC
Intel
-- 23.600 BABA
Alibaba
-- 124.730 PLTR
Palantir
-- 119.160 
$HilleVax (HLVX.US)$ Biomedical investment institution TANG ...
$HilleVax (HLVX.US)$ Biomedical investment institution TANG CAPITAL took advantage of the large decline in stock price to open a position this month, holding 9.5% of the shares. With the support of professional institutions, my venture capital position is also more secure. Hopefully, the clinical trials of HIL-216 multi-valent vaccine will proceed smoothly without any further issues.![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
🔥美股专业投资者🔥
⭕主投颠覆性科技与卫健类公司，关注公司护城河宽度与深度，以及能给公司带来高增长的潜在市场规模和现金余额
141
Followers
23
Following
230
Visitors
Follow
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
北美深蓝 OP :
The global viral gastroenteritis market is expected to reach $9.5 billion by 2032; 60% of viral gastroenteritis cases are caused by norovirus.
HIL-216 is another virus-like granular vaccine against norovirus and has been approved for development outside of China; compared to HIL-214, this vaccine can target more genotypes of norovirus.